Abstract Details
|
Taofiki A. Sunmonu, MD, FÂ鶹´«Ã½Ó³»
(Federal Medical Centre, Owo)
PRESENTER |
Dr. Sunmonu has nothing to disclose. |
| Morenikeji Komolafe, MD (Obafemi Awolowo University) | Dr. Komolafe has nothing to disclose. |
| Joseph F. Quinn, MD, FÂ鶹´«Ã½Ó³» (OHSU Neurology) | Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Olubunmi A. Ogunrin, MD (University of Benin) | No disclosure on file |
| No disclosure on file | |
| Sani A. Abubakar | No disclosure on file |
| No disclosure on file |